Skip to content
Review Open access

Real-world performance of pelvic MRI and abdominopelvic CT for nodal staging in higher-risk prostate cancer and the incremental clinical value of CT

Nov 2026 · World journal of urology · Vol 44 · 0 citations · 24 references
Medicine

Abstract

Conventional imaging with pelvic magnetic resonance imaging (MRI) and abdominopelvic computed tomography (CT) is still used for the staging of prostate cancer (PCa), particularly when molecular imaging is unavailable. mpMRI is currently recommended before prostate biopsy. We evaluated the agreement between MRI and CT for nodal and distant staging, their diagnostic accuracy against surgical nodal staging, and the real-world clinical utility of CT when pelvic MRI is already available. Among consecutive prostate biopsies, we retrieved patients with unfavorable intermediate- or high-risk PCa who underwent both pelvic MRI and abdominopelvic CT (and bone scan). Agreement for nodal staging was assessed using Cohen’s κ. Diagnostic performance was evaluated in patients undergoing radical prostatectomy with pelvic lymph node dissection, using final pathology as the reference standard. The clinical yield of CT was assessed post hoc, considering nodal or metastatic reclassification or urgent non-PCa-related findings. We included 323 consecutive patients. MRI and CT identified cN1 disease in 6.8% and 8.1% of cases, respectively, and showed moderate agreement for pelvic nodal staging (κ = 0.51), with higher agreement in non-surgical patients. Both modalities demonstrated very low sensitivity for nodal metastases (≤ 20%) compared with pathology, with area under the curve (AUC) < 0.60. In the subgroup of patients who also had molecular imaging available (n = 82) PSMA PET/CT showed superior performance (AUC = 0.86). In a post-hoc exploratory analysis, CT provided oncologically relevant information not detected by mpMRI in 11.0% of patients (number needed to scan [NNS] = 9.2). Considering also urgent non PCa-related findings, 14.1% of CT scans yielded potentially clinically relevant information and the NNS decreased to 7. Limitations include the retrospective design and the lack of centralized imaging review. Imaging strategies were evaluated observationally. Pelvic MRI and CT show moderate agreement for nodal staging but poor diagnostic accuracy. Although the incremental value of CT beyond pelvic MRI is limited, CT may occasionally provide additional clinically relevant information when PSMA PET/CT is unavailable or not readily accessible.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.